Polishchuk Alexei L, Cristian Lidia, Pinto Lawrence H, Lear James D, DeGrado William F
Department of Biochemistry and Biophysics, The Robert Wood Johnson Foundation, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA.
Department of Neurobiology and Physiology, Northwestern University, Evanston, IL 60208, USA.
Biochim Biophys Acta. 2014 Apr;1838(4):1082-7. doi: 10.1016/j.bbamem.2013.11.011. Epub 2013 Nov 22.
The influenza A/M2 protein is a homotetrameric single-pass integral membrane protein encoded by the influenza A viral genome. Its transmembrane domain represents both a crucial drug target and a minimalistic model system for transmembrane proton transport and charge stabilization. Recent structural and functional studies of M2 have suggested that the proton transport mechanism involves sequential extraviral protonation and intraviral deprotonation of a highly conserved His37 side chain by the transported proton, consistent with a pH-activated proton shuttle mechanism. Multiple tautomeric forms of His can be formed, and it is not known whether they contribute to the mechanism of proton shuttling. Here we present the thermodynamic and functional characterization of an unnatural amino acid mutant at His37, where the imidazole side chain is substituted with a 4-thiazolyl group that is unable to undergo tautomerization and has a significantly lower solution pKa. The mutant construct has a similar stability to the wild-type protein at pH8 in bilayers and is virtually inactive at external pH7.4 in a semiquantitative liposome flux assay as expected from its lower sidechain pKa. However when the external buffer pH is lowered to 4.9 and 2.4, the mutant shows increasing amantadine sensitive flux of a similar magnitude to that of the wild type construct at pH7.4 and 4.9 respectively. These findings are in line with mechanistic hypotheses suggesting that proton flux through M2 is mediated by proton exchange from adjacent water molecules with the His37 sidechain, and that tautomerization is not required for proton translocation. This article is part of a Special Issue entitled: Viral Membrane Proteins - Channels for Cellular Networking.
甲型流感病毒M2蛋白是一种由甲型流感病毒基因组编码的同四聚体单次跨膜整合膜蛋白。其跨膜结构域既是一个关键的药物靶点,也是跨膜质子转运和电荷稳定的简约模型系统。最近对M2的结构和功能研究表明,质子转运机制涉及被转运质子对高度保守的His37侧链进行的顺序性病毒外质子化和病毒内去质子化,这与pH激活的质子穿梭机制一致。His可以形成多种互变异构形式,目前尚不清楚它们是否有助于质子穿梭机制。在此,我们展示了His37处非天然氨基酸突变体的热力学和功能特性,其中咪唑侧链被4-噻唑基取代,该基团无法进行互变异构,且溶液中的pKa显著降低。在双层膜中,该突变体构建体在pH8时与野生型蛋白具有相似的稳定性,并且在外部pH7.4的半定量脂质体通量测定中几乎无活性,这与其较低的侧链pKa预期一致。然而,当外部缓冲液pH降至4.9和2.4时,该突变体分别在pH7.4和4.9时显示出与野生型构建体相似程度的、对金刚烷胺敏感的通量增加。这些发现符合如下机制假说:表明通过M2的质子通量是由相邻水分子与His37侧链之间的质子交换介导的,并且质子转运不需要互变异构。本文是名为:病毒膜蛋白 - 细胞网络通道的特刊的一部分。